Trial Profile
A retrospective study to evaluate long term efficacy of Infliximab in patients with refractory ulcerative colitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 03 Dec 2015 New trial record